The comparative effectiveness of contemporary treatment options for localized prostate cancer is one of the highest priority research questions according to the National Academy of Medicine (previously the Institute of Medicine).
1 Because patients with prostate cancer often have extended life expectancy, the quality-of-life (QOL) effects of different treatment options is a central consideration for many men in their decision-making process.